Jivanam Pharma Private Limited
About Jivanam Pharma Private Limited
Data last updated:
Jivanam Pharma Private Limited is a private limited company based in Panchkula, Haryana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 09 January 2023.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24290HR2023PTC109059. Its GSTIN is 06AAFCJ8861L1Z0 (Haryana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹10,000. It is led by directors including Milly Kumari and Priti Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sector 20, Panchkula, Haryana.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.3 Lakh, a growth of 128% compared to the previous year. For the same year it recorded a net loss of ₹1.5 Lakh (net margin -28.4%) and EBITDA of -₹1.5 Lakh (EBITDA margin -28.4%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Jivanam Pharma Private Limited's registered office is in Panchkula, Haryana.
- Registered AddressD/B – 12 Ahluwalia Complex, Sector 20, Panchkula, Haryana, India – 134109
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Jivanam Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Jivanam Pharma Private Limited, buy the company report.
Financials of Jivanam Pharma Private Limited
FY 2025 filings availableJivanam Pharma Private Limited reported revenue of ₹5.3 Lakh (up 128% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 128% in the latest year. EBITDA rose 59% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹1.5 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹1.5 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -28.4% | ||
| Net Profit Margin | -28.4% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Jivanam Pharma Private Limited, buy the company report.
Board of directors of Jivanam Pharma Private Limited
Jivanam Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Milly Kumari | Director | 09 Jan 2023 | 3 Years 9 Months | Current |
| Priti Kumari Also directs: Perys Global Private Limited | Director | 09 Jan 2023 | 3 Years 9 Months | Current |
| Veena Roy | Director | 09 Jan 2023 | 3 Years 9 Months | Current |
Peer comparison
Jivanam Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nakoda Health Solution Private Limited | ₹5.69 Lakh (FY 2025) | Mehkar, Maharashtra, India | ||||
| Herbalbyte Solutions (OPC) Private Limited | ₹5.62 Lakh (FY 2025) | Hyderabad, Telangana, India | ||||
| Humanglow Pharma Private Limited | ₹5.44 Lakh (FY 2024) | Nalagarh, Himachal Pradesh, India | ||||
| Ayonix Pharmaceutical Private Limited | ₹5.4 Lakh (FY 2025) | 548.0% | Aurangabad, Maharashtra, India | |||
| Gentle Care Lifescience Private Limited | ₹5.33 Lakh (FY 2025) | -12.0% | Delhi, India | |||
| Jivanam Pharma Private Limitedthis company | ₹5.3 Lakh (FY 2025) | -₹1.5 Lakh | -28.4% | 128.0% | Panchkula, Haryana, India | |
| Binay and Sons Pharmaceutical Industries Private Limited | ₹5.27 Lakh (FY 2024) | Ranchi, Jharkhand, India | ||||
| Medocfine Pharmaceutical Private Limited | ₹5.24 Lakh (FY 2024) | Navi Mumbai, Maharashtra, India | ||||
| Lunix Pharma India Private Limited | ₹5.15 Lakh (FY 2024) | Bengaluru, Karnataka, India | ||||
| Waaqa Healthcare Private Limited | ₹4.98 Lakh (FY 2024) | Gmc, Assam, India | ||||
| Tripler Trade and Industries Private Limited | ₹4.95 Lakh (FY 2025) | -87.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Jivanam Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Jivanam Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jivanam Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Jivanam Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAFCJ8861L1Z0 | Haryana | Active | 11 Jul 2023 |
To see the full GST registrations and return filing status of Jivanam Pharma Private Limited, buy the company report.
Recent activity
Jivanam Pharma Private Limited has 4 board changes on record since 2023: 3 appointments and 1 cessation. The latest: Sanjiv Kumar Srivastava ceased to be Director on 22 Jan 2024.
Frequently asked questions
Jivanam Pharma is an active private limited company based in Panchkula, Haryana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 09 January 2023 (3+ years old) and is registered under CIN U24290HR2023PTC109059.
Jivanam Pharma has 3 current directors:
- Milly Kumari - Director
- Priti Kumari - Director
- Veena Roy - Director
The latest financial statements of Jivanam Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Jivanam Pharma is 06AAFCJ8861L1Z0, registered in Haryana.
The CIN (Corporate Identification Number) of Jivanam Pharma is U24290HR2023PTC109059. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jivanam Pharma was incorporated on 09 January 2023, making it 3+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Jivanam Pharma by revenue are Nakoda Health Solution Private Limited, Herbalbyte Solutions (OPC) Private Limited, Humanglow Pharma Private Limited, Ayonix Pharmaceutical Private Limited, Gentle Care Lifescience Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Sanjiv Kumar Srivastava ceased to be Director on 22 Jan 2024. Milly Kumari was appointed as Director on 09 Jan 2023. Priti Kumari was appointed as Director on 09 Jan 2023. Jivanam Pharma has 4 board changes on record in total.
The registered office of Jivanam Pharma is at DB – 12 Ahluwalia Complex, Sector 20, Panchkula, Haryana, India – 134109.
Jivanam Pharma operates in the chemicals industry, in the manufacturing segment.
The compliance status of Jivanam Pharma is compliant as of 11 August 2026. The company is actively filing with the Registrar of Companies.